Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Leonardi

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|January 13, 2006
Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedureM A Saracino, R Mandrioli, L Mercolini, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|March 26, 1999
Growth failure and bone lesions due to desferrioxamine in thalassaemic patientsM Caruso-Nicoletti, D Di Bella, G Pizzarelli, et al.
Autoimmunity|February 24, 2001
The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cellsF Nicoletti, R Di Marco, F Patti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 31, 2017
Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non-Small Cell Lung CancerGiulia C Leonardi, Geoffrey R Oxnard, Andrea Haas, et al.
The British Journal of Dermatology|January 4, 2007
Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasisB Elewski, C Leonardi, A B Gottlieb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2000
Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccinationD F Hoft, C Leonardi, T Milligan, et al.
Immunology Letters|April 30, 1998
Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of tumor necrosis factor-alphaR Di Marco, P Zaccone, L Condorelli, et al.
Journal of Dairy Science|November 21, 2017
Efficacy of colostrum replacer versus maternal colostrum on immunological status, health, and growth of preweaned dairy calvesA Lago, M Socha, A Geiger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 2, 2018
Systematic review of the real-world evidence of adalimumab safety in psoriasis registriesB Strober, J Crowley, R G Langley, et al.
Tumori|January 5, 2002
3D-conformal radiation therapy in prostate cancer. Technical considerations after 5 years of experience and 334 patients treated at the Istituto Europeo di Oncologia of Milan, ItalyM Ghilezan, G Ivaldi, F Cattani, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
Journal of Pharmaceutical and Biomedical Analysis|January 13, 2006
Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedureM A Saracino, R Mandrioli, L Mercolini, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|March 26, 1999
Growth failure and bone lesions due to desferrioxamine in thalassaemic patientsM Caruso-Nicoletti, D Di Bella, G Pizzarelli, et al.
Autoimmunity|February 24, 2001
The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cellsF Nicoletti, R Di Marco, F Patti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 31, 2017
Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non-Small Cell Lung CancerGiulia C Leonardi, Geoffrey R Oxnard, Andrea Haas, et al.
The British Journal of Dermatology|January 4, 2007
Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasisB Elewski, C Leonardi, A B Gottlieb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2000
Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccinationD F Hoft, C Leonardi, T Milligan, et al.
Immunology Letters|April 30, 1998
Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of tumor necrosis factor-alphaR Di Marco, P Zaccone, L Condorelli, et al.
Journal of Dairy Science|November 21, 2017
Efficacy of colostrum replacer versus maternal colostrum on immunological status, health, and growth of preweaned dairy calvesA Lago, M Socha, A Geiger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 2, 2018
Systematic review of the real-world evidence of adalimumab safety in psoriasis registriesB Strober, J Crowley, R G Langley, et al.
Tumori|January 5, 2002
3D-conformal radiation therapy in prostate cancer. Technical considerations after 5 years of experience and 334 patients treated at the Istituto Europeo di Oncologia of Milan, ItalyM Ghilezan, G Ivaldi, F Cattani, et al.
Pageof 16